HLA class I and class II HLA DRB profiles in egyptian children with rheumatic valvular disease

Pediatric Cardiology

Volumn 31, Issue 5, 2010, Pages 650-656

  El Hagrassy, Nashwa ^a   El Chennawi, Farha ^b   Zaki, Maysaa El Sayed ^b   Fawzy, Hossam ^c   Zaki, Adel ^b   Joseph, Nabeil ^d  

^a OCTOBER 6 UNIVERSITY   (Egypt)

^b MANSOURA UNIVERSITY   (Egypt)

^c NATIONAL HEART INSTITUTE   (Egypt)

^d MANSOURA UNIVERSITY   (Egypt)

Author keywords

HLA class I; HLA class II; Rheumatic valvular disease

Indexed keywords

HLA A ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA B ANTIGEN; HLA C ANTIGEN; HLA DR ANTIGEN; HLA B52 ANTIGEN; HLA-B5 ANTIGEN;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; EGYPT; FEMALE; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; RHEUMATIC HEART DISEASE; RISK; SCHOOL CHILD; SEROTYPING; ALLELE; CASE CONTROL STUDY; GENETICS; IMMUNOLOGY;

ADOLESCENT; ADULT; ALLELES; CASE-CONTROL STUDIES; CHILD; EGYPT; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HLA-B ANTIGENS; HLA-DR ANTIGENS; HUMANS; MALE; RHEUMATIC HEART DISEASE; HLA-B52 ANTIGEN;

EID: 77955096449     PISSN: 01720643     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00246-010-9663-3     Document Type: Article

References (24)

1. Al-Sekait MA, Al-Sweliem AA, Tahir M (1990) Rheumatic heart disease in schoolchildren in western district, Saudi Arabia. J R Soc Health 110:15-19.
2. Ayoub EM, Barrett DJ, Maclaren NK, Krscher JP (1986) Association of class II human histocompatibility leukocyte antigens with rheumatic fever. J Clin Invest 77:2019-2026.
3. Bessen D, Jones KF, Fischetti VA (1989) Evidence for two distinct classes of streptococcal M protein and their relationship to rheumatic fever. J Exp Med 169:269-283.
4. Bisno AL (1994) Group A streptococcal infections and acute rheumatic fever. N Engl J Med 325:783-793.
5. De Vreese KR, Barylski F, Pughe M, Blaser C, Evans J, Norton G, Semana R, Holman P, Loiseau D, Masson M, Gielis A, De Brauwer I, De Canck G, Verpooten, Hulstaert F (2004) Performance characteristics of updated INNO-LiPA assays for molecular typing of human leukocyte antigen A (HLA-A), HLA-B, and HLA-DQB1 alleles. Clin Diagn Lab Immunol 11:430-432.
6. Fae KC, Diefenbach SD, Oshiro SE, Tanaka AC, Pomerantzeff PMA, Douay C, Charron D, Toubert A, Cunningham MW, Kalil J, Guilherme L (2006) Mimicry in recognition of cardiac myosin peptides by heart-intralesional T cell clones from rheumatic heart disease. J Immunol 176:5662-56707.
7. Girschick HJ, Guilherme L, Inman RD, Latsch K, Rihl M, Sherer Y, Shoenfeld Y, Zeidler H, Arienti S, Doria A (2008) Bacterial triggers and autoimmune rheumatic diseases. Clin Exp Rheumatol 26(48):S12-S17.
8. Goldberg AC, Kalil J, Kotb M et al (1997) HLA and rheumatic fever: 12th cytokines in acute rheumatic fever. Eur J Pediatr 156:25-29.
9. Guédez Y, Kotby A, El-Demellawy M, Galal A, Thomson G, Zaher S, Kassem S, Kotb M (1999) HLA class II associations with rheumatic heart disease are more evident and consistent among clinically homogeneous patients. Circulation 99:2784- 2790.
10. Guilherme L, Fae KC, Oshiro SE, Tanaka AC, Pomerantzeff P, Kalil J (2005) Rheumatic fever: how S. pyogenes-primed peripheral T cells trigger heart valve lesions. Ann NY Acad Sci 1051:132-140.
11. Guilherme L, Fae K, Oshiro S, Kalil J (2005) Cross reactivity of M-protein-reactive antibodies with human proteins. Exp Rev Mol Med 70:12.
12. Guilherme L, Fa KC, Higa F, Chaves L, Oshiro SE, Freschi de Barros S, Puschel C, Juliano MA, Tanaka AC, Spina G, Kalil J (2006) Towards a vaccine against rheumatic fever. Clin Dev Immunol 13:125-132.
13. Gündogdu F, Islamoglu Y, Pirim I, Gurlertop Y, Dogan H, Arslan S, Sevimli S, Aksakal E, Senocak H (2007) Human leukocyte antigen (HLA) class I and II alleles in Turkish patients with rheumatic heart disease. J Heart Valve Dis 16(3):293-299.
14. Haydardedeoǧlu FE, Tutkak H, Köse K, Düzgün N (2006) Genetic susceptibility to rheumatic heart disease and streptococcal pharyngitis: association with HLA-DR alleles. Tissue Antigens 68(4):293-296.
15. Komo NVT (2007) Epidemiology and prevention of valvular heart diseases and infective endocarditis in Africa. Heart 93:1510-1519.
16. Kumar R (1995) Controlling rheumatic heart disease in developing countries. World Health Forum 16(1):47-51.
17. Maharaj B, Hammond MG, Appadoo B, Leary WP, Pudifin DJ (1987) HLA-A, B, DR and DQ antigens in Black patients with severe chronic heart disease. Circulation 76:259-261.
18. Noah PK (1994) Trends in acute rheumatic fever. The Barbados experience. J Trop Pediatr 40(2):94-96.
19. Osman BA, Mokhtar S, Gharieb S, Shafee SE (2000) Genetic susceptibility in patients with rheumatic heart disease an Egyptian study. Thesis. Cairo Faculty of Medicine.
20. Ozkan M, Carin M, Sonmez G, Senocak M, Ozdemir M, Yakut C (1993) HLA antigens in Turkish race with rheumatic heart disease. Circulation 87:1974-1978.
21. Rehman S, Akhtar N, Ahmad W, Ayub Q, Mehdi SQ, Mohyuddin A (2007) Human leukocyte antigen (HLA) class II association with rheumatic heart disease in Pakistan. J Heart Valve Dis 16(3):300-304.
22. Stanevicha V, Eglite J, Zavadska D, Sochnevs A, Shantere R, Gardovska D (2007) HLA class II DR and DQ genotypes and haplotypes associated with rheumatic fever among a clinically homogeneous patient population of Latvian children. Arthritis Res Ther 9(3):R58.
23. Terasaki PI, McClelland JD, Park MS, McCurdy B (1973) Microdroplet lymphocyte cytotoxicity test. In: Brand DL, Ray JG (eds) Manual of tissue typing techniques. NIH, Bethesda, p 54.
24. WHO Cardiovascular Diseases Unit and Principal Investigators (1992) WHO programme for the prevention of rheumatic fever/rheumatic heart diseases in 16 developing countries: report from Phase 1 (1986-90). Bull WHO 70(2):213-218.